scholarly journals Safety and efficacy of the partial adenosine A1 receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced ejection fraction: a phase IIb, randomized, double‐blind, placebo‐controlled trial

2019 ◽  
Vol 21 (11) ◽  
pp. 1426-1433 ◽  
Author(s):  
Adriaan A. Voors ◽  
Jeroen J. Bax ◽  
Adrian F. Hernandez ◽  
Antonieta B. Wirtz ◽  
Akos F. Pap ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Receptor Agonist ◽  
Controlled Trial ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Reduced Ejection Fraction ◽  
Adenosine A1 ◽  
A1 Receptor

scholarly journals A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

2019 ◽  
Vol 22 (9) ◽  
pp. 1628-1637 ◽  
Author(s):  
Anders Hostrup Larsen ◽  
Niels Jessen ◽  
Helene Nørrelund ◽  
Lars Poulsen Tolbod ◽  
Hendrik Johannes Harms ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Heart Failure Patients ◽  
Insulin Resistant ◽  
Myocardial Efficiency

Effect of Yangxinkang Tablets (养心康片) on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial

2015 ◽  
Vol 21 (10) ◽  
pp. 733-742 ◽  
Author(s):  
Shao-xiang Xian ◽  
Zhong-qi Yang ◽  
Pei-hua Ren ◽  
Xiao-han Ye ◽  
Sui-lin Ye ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document